新日本製薬株式会社 (Corporate ID: 5290001023017) is a major listed enterprise operating in the 農業，林業 sector headquartered in 福岡県福岡市中央区大手門１丁目４番７号. Led by 代表取締役 CEO 後藤 孝洋. Latest operational metrics report annual revenue: ¥40.3B JPY, workforce: 309 employees, capital: ¥4.2B JPY. Fully registered under Japan's National Tax Agency Qualified Invoice System (Invoice No: T5290001023017). Official contact (092-303-8318), corporate governance, and multi-year financial statements are openly accessible on Kigyou-list.
「(Company business strengths, flagship services, or recruitment messages will be prioritized and displayed here at the top of your corporate profile)」
13-digit Corporate Number "5290001023017" was officially assigned by the National Tax Agency Commissioner with corporate name "新日本製薬株式会社".
| Shareholder Name | Ownership Ratio |
|---|---|
| 山田 英二郎 | 19.40% |
| 株式会社ラプリス | 14.10% |
| 山田 恵美 | 13.85% |
| 公益財団法人新日本先進医療研究財団 | 8.22% |
| 日本マスタートラスト信託銀行株式会社(信託口) | 5.07% |
Cross-check reviews, press releases, and compliance background across top Japanese portals.
The official representative phone number for 新日本製薬株式会社 is 092-303-8318 (FAX: 092-720-5800). Head office is located at 福岡県福岡市中央区大手門１丁目４番７号. Verified contact channels and executive directories are accessible on Kigyou-list.
新日本製薬株式会社's official 13-digit National Tax Agency Corporate Number is 5290001023017. It is officially registered as a Qualified Invoice Issuer under Japan's consumption tax invoice system with registration ID T5290001023017.
新日本製薬株式会社 is officially registered and headquartered at Postal Code 8100074, 福岡県福岡市中央区大手門１丁目４番７号. Complete regional jurisdiction and legal relocation history are verified via Japan's National Tax Agency.
Outreach to 新日本製薬株式会社 or acquire targeted lookalike company datasets.
新日本製薬株式会社に関連する公的異動登記および福岡県の各カテゴリ別データベースへの直通インデックスです。 最新の法人登記データや採用活動の動向を各ハブにて毎日自動更新しています。
新日本製薬株式会社 currently employs 309 personnel. Most recently reported annual revenue stands at ¥40.3B JPY.
The official representative of 新日本製薬株式会社 is 代表取締役 CEO 後藤 孝洋, with a registered capital of ¥4.2B JPY. The company is publicly traded on the 東証.
On Kigyou-list, users can review verified financial metrics, legal registry history, corporate signals (hiring, subsidies, trademarks), and export standardized CSV datasets for B2B intelligence.